Skip to content

Falls in stroke survivors

A randomised controlled trial to evaluate the clinical and cost effectiveness of the Stroke Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33761832
Enrollment
464
Registered
2025-10-10
Start date
2026-03-04
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System

Interventions

The study is investigating whether the SAF programme compiling of a checklist, action plan and supporting materials (such as training) can reduce falling in patients who are discharged to their home a

Sponsors

University of Nottingham
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over 2. Confirmed stroke diagnosis in hospital 3. Planned to be discharged to home, (including sheltered accommodation, somebody else's home) 4. Able to report number of falls and complete questionnaires either individually or via a carer/family member/personal consultee 5. Ability to provide informed consent from participant or an advice form from Personal consultee

Exclusion criteria

Exclusion criteria: 1. Resident of, or being discharged to a care home 2. And/or on end-of-life pathway

Design outcomes

Primary

MeasureTime frame
Annual fall rate: The rate of reported participant falls in the 12 months following randomisation

Secondary

MeasureTime frame
1. Number of falls reported in each 3-month period (months 1-3, 4-6, 7-9, 10-12) and over all 12 months 2. Number and severity of falls categorised using the National Database of Nursing Quality Indicators (NDNQI) scale monthly for 12 months 3. Fear of falling measured using Short Falls Efficacy Scale-International (Short FES-I) at baseline, 3, 6, 9 and 12 months 4. Activities of daily living measured using Nottingham Extended Activities of Daily Living (NEADL) at baseline, 3, 6, 9 and 12 months 5. Psychological stress (participants and carers (optional)) measured using Patient Health Questionnaire (PHQ-8) at baseline, 3, 6, 9 and 12 months 6. Quality of life measured using EQ-5D-5L at baseline, 3, 6, 9 and 12 months 7. Resource use measured using questionnaire at baseline, 3, 6, 9 and 12 months

Countries

England, United Kingdom, Wales

Contacts

Public ContactChloe Dyche
chloe.dyche@nottingham.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026